1. Chen, Changhao, He, Wang, Huang, Jian, Dong, Wen, Lin, Tianxin. 2018. LNMAT1 promotes lymphatic metastasis of bladder cancer via CCL2 dependent macrophage recruitment. In Nature communications, 9, 3826. doi:10.1038/s41467-018-06152-x. https://pubmed.ncbi.nlm.nih.gov/30237493/
2. Martin, Timothy D, Patel, Rupesh S, Cook, Danielle R, Haigis, Kevin M, Elledge, Stephen J. 2021. The adaptive immune system is a major driver of selection for tumor suppressor gene inactivation. In Science (New York, N.Y.), 373, 1327-1335. doi:10.1126/science.abg5784. https://pubmed.ncbi.nlm.nih.gov/34529489/
3. Singh, B, Chitra, J, Selvaraj, P. 2013. CCL2, CCL3 and CCL4 gene polymorphisms in pulmonary tuberculosis patients of South India. In International journal of immunogenetics, 41, 98-104. doi:10.1111/iji.12085. https://pubmed.ncbi.nlm.nih.gov/23998687/
4. Tang, X, Asano, M, O'Reilly, A, Yang, Y, Amar, S. . p53 is an important regulator of CCL2 gene expression. In Current molecular medicine, 12, 929-43. doi:. https://pubmed.ncbi.nlm.nih.gov/22804246/
5. Wei, Meng, Xie, Qingyun, Zhu, Jun, Mo, Liweng, Wang, Shuai. 2016. MicroRNA-33 suppresses CCL2 expression in chondrocytes. In Bioscience reports, 36, . doi:10.1042/BSR20160068. https://pubmed.ncbi.nlm.nih.gov/27129293/
6. Sun, Tong, Mary, Lee Gwo-Shu, Oh, William K, Pienta, Kenneth J, Kantoff, Philip W. 2010. Inherited variants in the chemokine CCL2 gene and prostate cancer aggressiveness in a Caucasian cohort. In Clinical cancer research : an official journal of the American Association for Cancer Research, 17, 1546-52. doi:10.1158/1078-0432.CCR-10-2015. https://pubmed.ncbi.nlm.nih.gov/21135144/
7. Alagarasu, Kalichamy, Bachal, Rupali V, Damle, Indraneel, Shah, Paresh S, Cecilia, Dayaraj. 2015. Association of FCGR2A p.R131H and CCL2 c.-2518 A>G gene variants with thrombocytopenia in patients with dengue virus infection. In Human immunology, 76, 819-22. doi:10.1016/j.humimm.2015.09.042. https://pubmed.ncbi.nlm.nih.gov/26429304/
智鼠故事 
